MoneyWorks4Me

The March 2023 quarter revenue stood at Rs. 6991.40 millions, up 19.80% as compared to Rs. 5835.80 millions during the corresponding quarter last year.The Company has registered profit of Rs. 886.70  millions for the quarter ended March 2023, a growth of 7.19%  over Rs. 827.20 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 1647.40 millions compared to 1234.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 6991.40 5835.80 19.80 28841.60 21898.80 31.70 28841.60 21898.80 31.70
Other Income 33.00 18.50 78.38 86.50 386.10 -77.60 86.50 386.10 -77.60
PBIDT 1647.40 1234.50 33.45 6733.40 5475.20 22.98 6733.40 5475.20 22.98
Interest 122.60 15.80 675.95 343.10 49.50 593.13 343.10 49.50 593.13
PBDT 1524.80 1218.70 25.12 6390.30 5425.70 17.78 6390.30 5425.70 17.78
Depreciation 305.60 217.90 40.25 1119.90 712.80 57.11 1119.90 712.80 57.11
PBT 1219.20 1000.80 21.82 5270.40 4712.90 11.83 5270.40 4712.90 11.83
TAX 332.50 173.60 91.53 1381.50 1102.90 25.26 1381.50 1102.90 25.26
Deferred Tax 109.00 -136.40 -179.91 548.00 -122.10 -548.81 548.00 -122.10 -548.81
PAT 886.70 827.20 7.19 3888.90 3610.00 7.73 3888.90 3610.00 7.73
Equity 154.80 154.60 0.13 154.80 154.60 0.13 154.80 154.60 0.13
PBIDTM(%) 23.56 21.15 11.39 23.35 25.00 -6.62 23.35 25.00 -6.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..